Emerald Clinics sees potential in filling evidence gap for cannabinoid products
Emerald operates a network of clinics specialised in assessing the safety and efficacy of unregistered medicines including cannabinoid medicines.
Company
.:[TICKER]
Mining and Minerals Industries Holdings Pte Ltd is focused on the Philippines which has the second largest gold and fourth largest copper reserves in the world. The company is planning a listing on the Singapore Stock Exchange.
170 stories · page 9 of 9
Emerald operates a network of clinics specialised in assessing the safety and efficacy of unregistered medicines including cannabinoid medicines.
The company specialises in the appropriate use of unregistered medicines, including cannabinoid treatments, and the creation of robust and ethically sourced real-world clinical evidence.
The company is drilling at the El Zorro Gold Project to extend the mineralised zone at Coquetas which has previously reported multiple, wide, high-grade gold intersections.
The collagen ropes enhance soft tissue repairs to areas such as anterior cruciate ligaments or ACLs.
Investments and investor services
Despite a sharp price correction in 2018, shrinking supply sources and growing demand for battery chemicals are predicted to sustain cobalt prices into the 2020s.
Investments and investor services
Despite its enormous potential as a new energy mineral, steel remains the primary price driver for vanadium.
Investments and investor services
Price corrections were the norm for base metals in 2018 and ongoing uncertainty around trade has offset price upside from declining supply and stronger demand.
The oil industry faces political and financial uncertainty as global production is curtailed to prop up the volatile price of crude.
The lithium price faces a slow downward trend to 2022 as the market shifts into a supply surplus in 2019.
Investments and investor services
Sustained demand growth and forecast supply cuts have not yet translated into higher copper prices as the Chinese economy slows.